# Boston Scientific Corp: insider transactions

SEC CIK 885725. Roles and transactions as reported on Form 4. Latest Form 4 filed 2021-07-14.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Pulmonx Corp](/companies/lung.md) | 10% owner | 17 | 2020-10-05 | 2021-07-13 |

## Transactions: 17

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2021-07-13 | [Pulmonx Corp](/companies/lung.md) | Sale (S) | 2,500,000 | $37.45 | $93.6m | [Form 4](/filings/0001225208-21-010646.md) |
| 2021-04-06 | [Pulmonx Corp](/companies/lung.md) | Sale (S) | 650,000 | $43.60 | $28.3m | [Form 4](/filings/0001225208-21-006650.md) |
| 2021-03-30 | [Pulmonx Corp](/companies/lung.md) | Sale (S) | 1,350,000 | $40.80 | $55.1m | [Form 4](/filings/0001225208-21-006217.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C), derivative | 2,081,909 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C), derivative | 3,787,878 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C), derivative | 6,215 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C), derivative | 542 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C), derivative | 23,180 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C), derivative | 47,536 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C), derivative | 40,705 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C) | 542 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C) | 6,215 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C) | 23,180 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C) | 40,705 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C) | 47,536 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C) | 2,081,909 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |
| 2020-10-05 | [Pulmonx Corp](/companies/lung.md) | Conversion (C) | 3,787,878 | $0.00 | $0 | [Form 4](/filings/0001225208-20-012257.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 11:33 ET. No prices; not investment advice.